Evidence Intelligence™
- EvidenceScore™
- Strong
- Score 79 · Based on 3 studies
- ImpactScore™
- 83
- Positive
- ConsistencyScore™
- 100
- consistent
Estudios de apoyo: Basado en 3 estudios
Add to Evidence TrackerResumen de Investigación
Analyzed using Evidence Intelligence™
Artificial pancreas may improve glucose control in type 1 diabetes
Última actualización 18 de agosto de 2026
Key finding
HCL had a lower mean blood glucose of 6.93 ± 0.99 mmol/L compared to MDI's 8.03 ± 2.17 mmol/L.
Android‐HCL therapy compared to insulin multi‐injection therapy in patients with type 1 diabetes.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
Android‐HCL therapy compared to insulin multi‐injection therapy in patients with type 1 diabetes.
Clinical relevance
This study evaluated Android‐HCL therapy compared to insulin multi‐injection therapy in patients with type 1 diabetes.
Keep in mind
Limitations were not clearly described in the extracted text.
Published in
Referencia de la Revista
Publication details and source links for this paper.
Shaohua L, Pin L, Haosi L, et al. Efficacy and Safety of Artificial Pancreas in Patients with Type 1 Diabetes Mellitus. Case Reports in Endocrinology. 2026;2026. doi:10.1155/crie/8925266
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Hybrid closed-loop system, Insulin therapy and Blood glucose, Hypoglycemia events, Time above range, and 2 more.
This study contributes evidence to
Primary intervention
Hybrid closed-loop system
Primary outcomes
- Blood glucose
- Hypoglycemia events
- Time above range
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
10
Evidence pairs
10
Relationships
4
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 72
4
Related topics
10
Evidence pairs
599
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 10 evidence relationships
- Includes primary outcome data
- Linked to 4 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Agrega evidencia relacionada a tu Evidence Tracker
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Relación de evidencia
Insulin Delivery Systems and CGM Time in Range
Evidencia relacionada
Relación de evidencia
Insulin Delivery Systems and Hypoglycemia
Guardar evidencia
Relación de evidencia
Insulin Therapies and Fasting Glucose
Guardar evidencia
Core evidence
Study findings
The primary outcomes reported in this study.
Hypoglycemia events
Hybrid closed-loop system → Hypoglycemia events
Hybrid closed-loop system → Hypoglycemia events
Evidence Intelligence™
- EvidenceScore™
- Strong
- Score 79 · Based on 4 studies
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 35
- mixed
Estudios de apoyo: Basado en 4 estudios
Add to Evidence TrackerTime above range
Hybrid closed-loop system → Time above range
Hybrid closed-loop system → Time above range
Evidence Intelligence™
- EvidenceScore™
- 78
- Strong
- ImpactScore™
- 83
- Positive
- ConsistencyScore™
- 100
- consistent
Estudios de apoyo: Basado en 3 estudios
Add to Evidence TrackerTime below range
Hybrid closed-loop system → Time below range
Hybrid closed-loop system → Time below range
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 75
- Positive
- ConsistencyScore™
- 35
- mixed
Estudios de apoyo: Basado en 2 estudios
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- 86
- Strong
- ImpactScore™
- 79
- Positive
- ConsistencyScore™
- 70
- generally_consistent
Estudios de apoyo: Basado en 12 estudios
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- 77
- Strong
- ImpactScore™
- 67
- Slightly Positive
- ConsistencyScore™
- 35
- mixed
Estudios de apoyo: Basado en 3 estudios
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Strong
- Score 79 · Based on 3 studies
- ImpactScore™
- 67
- Slightly Positive
- ConsistencyScore™
- 35
- mixed
Estudios de apoyo: Basado en 3 estudios
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 75
- Positive
- ConsistencyScore™
- 35
- mixed
Estudios de apoyo: Basado en 2 estudios
Add to Evidence TrackerEvidence Intelligence™
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- 82
- Strong
- ImpactScore™
- 70
- Positive
- ConsistencyScore™
- 60
- generally_consistent
Estudios de apoyo: Basado en 5 estudios
Add to Evidence TrackerEvidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Insulin Delivery Systems and CGM Time in Range, Insulin Therapies and CGM Time in Range.
Relaciones de evidencia relacionadas
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Devices & Technology
Insulin Delivery Systems → CGM Time in Range
Devices & Technology
Evidence Intelligence™
- EvidenceScore™
- 86
- Strong
- ImpactScore™
- 79
- Positive
- ConsistencyScore™
- 70
- generally_consistent
Estudios de apoyo: Basado en 12 estudios
View evidenceMedications
Insulin Therapies → CGM Time in Range
Medications
Evidence Intelligence™
- EvidenceScore™
- 82
- Strong
- ImpactScore™
- 70
- Positive
- ConsistencyScore™
- 60
- generally_consistent
Estudios de apoyo: Basado en 5 estudios
View evidenceIncluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
CGM Time in Range Evidence Hub
All studies measuring CGM Time in Range
12 studies
outcome_hubMeasures CGM Time in Range as a key outcome.
Insulin Delivery Systems Evidence Hub
All studies on Insulin Delivery Systems
12 studies
intervention_hubContributes to Insulin Delivery Systems evidence base.
Insulin Therapies Evidence Hub
All studies on Insulin Therapies
5 studies
intervention_hubContributes to Insulin Therapies evidence base.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explora más en Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on Hybrid closed-loop system and Time in range
Intervention: Hybrid closed-loop systemOutcome: Time in range
12 results
All studies on Insulin therapy and Time in range
Intervention: Insulin therapyOutcome: Time in range
5 results
All studies on Hybrid closed-loop system
Intervention: Hybrid closed-loop system
12 results
All studies on Insulin therapy
Intervention: Insulin therapy
5 results
All studies measuring Time in range
Outcome: Time in range
12 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Insulin Delivery Systems improve cgm time in range?
Strong Evidence
Insulin Delivery Systems may improve CGM Time in Range.
ConsistencyScore™: Results are generally consistent across studies.
Ranked evidence signals
- 1
Time in range
EvidenceScore™ Strong | EvidenceScore™ 86.0 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study
- 2
Time above range
EvidenceScore™ Strong | EvidenceScore™ 78.3 | moderate positive | ConsistencyScore™ Consistent | 1 study
- 3
Time below range
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 1 study
Why this answer: This answer is based on 20 supporting studies with generally consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
Does Insulin Delivery Systems affect hypoglycemia?
Strong Evidence
Insulin Delivery Systems may improve Hypoglycemia.
ConsistencyScore™: Results are mixed and should be interpreted cautiously.
Evidence caveat: The available evidence reports mixed findings.
Ranked evidence signals
- 1
Hypoglycemia events
EvidenceScore™ Strong | EvidenceScore™ 79.0 | neutral | ConsistencyScore™ Mixed | 1 study
Why this answer: This answer is cautious because the available studies report mixed findings.
Limitations
- Population details are unavailable.
Does Insulin Therapies improve fasting glucose?
Strong Evidence
Insulin Therapies may improve Fasting Glucose.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Blood glucose
EvidenceScore™ Strong | EvidenceScore™ 77.4 | weak positive | ConsistencyScore™ Mixed | 1 study
Why this answer: This answer is based on 8 supporting studies with consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
Does Insulin Therapies improve cgm time in range?
Strong Evidence
Insulin Therapies appears to improve CGM Time in Range.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Time below range
EvidenceScore™ Strong | EvidenceScore™ 85.1 | neutral | ConsistencyScore™ Unclear | 1 study
- 2
Time in range
EvidenceScore™ Strong | EvidenceScore™ 81.8 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study
- 3
Time above range
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 1 study
Why this answer: This answer is based on 10 supporting studies with consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
Semaglutide with Insulin Improves Diabetes Control and Kidney HealthHybrid Closed-Loop Insulin Improves Glycemic Control in YouthClosed-loop therapy may improve sleep quality in young people with T1DOpen-source AID improves glycemic control in type 2 diabetes during surgeryVildagliptin improves glycemic control in type 2 diabetes patients on insulin
Sin anuncios. Sin rastreo.
Centrada en la evidencia, no en la publicidad.
Segura y privada
Tus datos siempre están protegidos.
Siempre al día
Se agregan nuevos estudios todos los días.